Ventyx Biosciences, Inc.
VTYX
$2.50
$0.0050.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.51% | 16.73% | -10.33% | 17.17% | 17.50% |
| Total Depreciation and Amortization | 13.02% | 1.94% | -2.22% | -22.55% | 1.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.19% | 8.84% | -6.08% | -32.93% | 14.04% |
| Change in Net Operating Assets | -176.82% | 180.21% | -182.54% | 129.15% | -50.88% |
| Cash from Operations | -10.62% | 34.44% | -44.51% | 48.48% | 7.80% |
| Capital Expenditure | -166.67% | -- | 100.00% | 65.71% | 17.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 340.46% | -137.58% | 138.76% | -279.92% | -9.49% |
| Cash from Investing | 340.18% | -137.60% | 138.73% | -280.82% | -9.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,750.00% | -- | -- | 22,062.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.09% | 3,064.90% | -100.94% | 16,341.71% |
| Foreign Exchange rate Adjustments | 151.07% | -221.35% | 2,233.33% | -80.00% | 94.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.36% | -265.57% | 120.64% | -211.80% | 1,895.25% |